GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » Float Percentage Of Total Shares Outstanding

Hikma Pharmaceuticals (Hikma Pharmaceuticals) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 13, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hikma Pharmaceuticals's float shares is 0.00 Mil. Hikma Pharmaceuticals's total shares outstanding is 221.89 Mil. Hikma Pharmaceuticals's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hikma Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hikma Pharmaceuticals's Institutional Ownership is 37.55%.

Hikma Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Hikma Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/221.89
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hikma Pharmaceuticals (Hikma Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:HCM LSE:INDV LSE:BMK LSE:APH LSE:AGY LSE:ANCR LSE:EAH LSE:CEL LSE:VLG LSE:PXS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
HKMPY:USA HIKl:UK HIK:UK H5P:Germany
Address
1 New Burlington Place, London, GBR, W1S 2HR
Website
https://www.hikma.com
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.